In focus · trending topic

Merck & Co.s systemic

1 stories · following the connections

PROVECTUS BIOPHARMACEUTICALS COMPLETES ENROLLMENT OF PHASE 1B TRIAL OF PV-10 IN COMBINATION WITH KEYTRUDA® IN PATIENTS WITH METASTATIC MELANOMA

By Nasdaq OMXMay 7, 2018, 12:01 PM UTC